Dipsanoside A
(Synonyms: 续断苷A) 目录号 : GC35869
Dipsanoside A 是一种来自川续断 (Dipsacus asper) 的新型四环苷类葡萄糖苷。川续断是一种在中国广泛存在的多年生植物，被用于传统中药中已有数百年，可以作为补品，作为骨质细胞的分裂促进剂，以及胚胎安全剂等。
Cas No.:889678-62-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Dipsanoside A is a novel tetrairidoid glucoside from Dipsacus asper. Dipsacus asper Wall., a perennial plant widespread in China, has been used in traditional Chinese medicine for hundreds of years as a tonic for refreshment, as a fissiparism promoter of the osseous cells, and as an embryo security agent, etc[1].
[1]. Tian, X.-Y. et al. Two Novel Tetrairidoid Glucosides from Dipsacus asper. Organic Letters, 2006,8(10), 2179-2182.
| Cas No. | 889678-62-0 | SDF | |
| 别名 | 续断苷A | ||
| 分子式 | C66H90O37 | 分子量 | 1475.4 |
| 溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 0.6778 mL | 3.3889 mL | 6.7778 mL |
| 5 mM | 0.1356 mL | 0.6778 mL | 1.3556 mL |
| 10 mM | 0.0678 mL | 0.3389 mL | 0.6778 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Divergent Total Syntheses of Hetero-Oligomeric Iridoid Glycosides
Org Lett 2023 Jan 20;25(2):347-352.PMID:36607173DOI:10.1021/acs.orglett.2c03965.
Divergent total syntheses of the hetero-oligomeric iridoid glycosides mainly found in Dipsacus asper were achieved. Thus, loganin (1), which is important as a monomer unit, was efficiently synthesized by stereoselective reductive cyclization using secologanin (2) as a substrate. Sequential condensation reactions of derivatives of 1 and 2 as monomer units led to the first enantioselective total syntheses of the heterooligomers cantleyoside, (E)-aldosecologanin, dipsaperine, (3R, 5S)-5-carboxyvincosidic acid 22-loganin ester, and Dipsanoside A.
Comparative analysis of anti-osteoporosis efficacy in Radix Dipsaci before and after processing with salt based on spectrum-effect relationship
J Pharm Biomed Anal 2022 Nov 30;221:115078.PMID:36183633DOI:10.1016/j.jpba.2022.115078.
Radix Dipsaci (RD) is the dry root of the Dipsacus asper Wall. ex DC., which has the effect of strengthening muscles and bones. The purpose of this study was to find the main active ingredients that could improve the anti-osteoporosis efficacy of RD after processing with salt. The fingerprints of raw and salt-processed RD were established by HPLC-DAD to determine the common components. Then, an experimental study on the anti-osteoporosis efficacy was carried out to compared the difference in the efficacy between raw and salt-processed RD. Pharmacological results showed that, compared with the model group, both the raw and salt-processed RD were able to increase the Ca, bone mineral content, bone mineral density, trabeculae bone area and number of trabeculae bone of rats, and reduce the P, alkaline phosphatase, osteocalcin and trabecular bone separation of rats. Under the same dose, the pharmacological effect of salt-processed RD group was better than that of raw RD group. Finally, spectrum-effect relationship between fingerprints and anti-osteoporosis efficacy of RD was assessed by grey relational analysis and entropy method to screening out the ingredients that affect the anti-osteoporosis efficacy in RD after processing with salt. The results showed that the anti-osteoporosis efficacy of salt-processed RD was stronger than that of raw RD, and the pharmacologically active ingredients that improved its anti-osteoporosis efficacy after processing with salt were peak 4, peak 7 (caffeic acid), peak 8 (loganin), peak 12 (isochlorogenic acid C), peak 13 (Dipsanoside A) and peak 14. As far as we known, this was the first time to establish the spectrum-effect relationship between RD and anti-osteoporosis efficacy, which laid the foundation for the follow-up research on the pharmacodynamic components and molecular mechanism of RD.